Ezetimibe Impurity 30 | CAS 2512202-06-9 - Request Quote
Ezetimibe Impurity 30
| SZ CAT No: | SZ-E026082 |
| CAS No | 2512202-06-9 |
| Mol.F. | C20H20FNO4 |
| Mol.Wt. | 357.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ezetimibe Impurity 30 is chemically (4S)-3-[(5S)-5-(2-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one. Ezetimibe Impurity 30 is supplied with detailed characterization data compliant with regulatory guideline. Ezetimibe Impurity 30 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ezetimibe.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2512202-06-9
Purchase 2512202-06-9
Order 2512202-06-9
Enquire 2512202-06-9
price of 2512202-06-9
2512202-06-9 Supplier
2512202-06-9 Manufacturer
2512202-06-9 Exporter
buy high quality Ezetimibe Impurity 30
Purchase Ezetimibe Impurity 30
Ezetimibe Impurity 30 suppliers
Ezetimibe Impurity 30 manufacturers
Ezetimibe Impurity 30 price
Order Ezetimibe Impurity 30
Enquire Ezetimibe Impurity 30
Ezetimibe Impurity 30 cost
Ezetimibe Impurity 30 Supplier
Ezetimibe Impurity 30 Distributor
Ezetimibe Impurity 30 for Method Validation
Ezetimibe Reference Standard
Ezetimibe Impurity 30 for ANDA Filing
Ezetimibe Impurity 30 for Forced Degradation Studies
Ezetimibe Impurity 30 Identification Standards
Ezetimibe Impurity 30 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.